Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

NPPA revokes its earlier direction refusing discontinuation of GSK's antifungal formulation: Gireesh Babu, New Delhi Saturday ...

Sun Pharmaceutical Industries clocked a net profit of ₹3,118 crore, for the second quarter ended September 30, up 2.6 per ...

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part 2 of a 2-part interview related to his presentation at CPHI Europe 2025.

The Immunosuppressants API market offers significant growth potential driven by increasing prevalence of autoimmune diseases ...

Key opportunities in the U.S. pharmaceutical market include growth in specialty drugs and personalized medicine, driven by ...

Aurobindo Pharma reported September quarter consolidated net profit rose nearly 4% to ₹848 crore compared with ₹817 crore a ...

DELRAY BEACH, Fla., Oct. 15, 2025 /PRNewswire/ -- The global Active Pharmaceutical Ingredients (API) Market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to ...

To mitigate these challenges, it is critical to identify and implement an appropriate enabling formulation strategy early in the development process. Doing so can de-risk your program and reduce costs ...

Deven Choksey is bullish on Alembic Pharmaceutical has recommended buy rating on the stock with a target price of Rs 1,132 in ...

Granules India advanced 2.04% to Rs 581.15 after the company announced that it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its API Unit-I ...